Financhill
Sell
42

NVST Quote, Financials, Valuation and Earnings

Last price:
$18.97
Seasonality move :
-0.55%
Day range:
$18.45 - $18.88
52-week range:
$15.15 - $25.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
1.05x
Volume:
2.2M
Avg. volume:
2M
1-year change:
-22.28%
Market cap:
$3.2B
Revenue:
$2.6B
EPS (TTM):
-$7.77

Analysts' Opinion

  • Consensus Rating
    Envista Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 10 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $21.33, Envista Holdings has an estimated upside of 13.48% from its current price of $18.80.
  • Price Target Downside
    According to analysts, the lowest downside price target is $17.00 representing 100% downside risk from its current price of $18.80.

Fair Value

  • According to the consensus of 14 analysts, Envista Holdings has 13.48% upside to fair value with a price target of $21.33 per share.

NVST vs. S&P 500

  • Over the past 5 trading days, Envista Holdings has underperformed the S&P 500 by -5.57% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Envista Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Envista Holdings revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Envista Holdings reported revenues of $601M.

Earnings Growth

  • Envista Holdings earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Envista Holdings reported earnings per share of $0.05.
Enterprise value:
3.7B
EV / Invested capital:
0.82x
Price / LTM sales:
1.30x
EV / EBIT:
--
EV / Revenue:
1.46x
PEG ratio (5yr expected):
--
EV / Free cash flow:
13.44x
Price / Operating cash flow:
11.89x
Enterprise value / EBITDA:
27.81x
Gross Profit (TTM):
$1.3B
Return On Assets:
-21.71%
Net Income Margin (TTM):
-53.42%
Return On Equity:
-35.84%
Return On Invested Capital:
-25.62%
Operating Margin:
3.48%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $2.6B $2.6B $2.5B $631.3M $601M
Gross Profit $1.5B $1.5B $1.3B $363.3M $317.3M
Operating Income $277.3M $322.3M $125M $83.3M $20.9M
EBITDA $438.2M $464.7M -$1.1B $90.8M $58.8M
Diluted EPS $1.43 $1.08 -$7.77 $0.12 $0.05
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $1.4B $1.8B $1.4B $1.6B $1.8B
Total Assets $6.6B $6.6B $6.4B $6.7B $5.5B
Current Liabilities $678.9M $1.3B $1.3B $746.8M $865.5M
Total Liabilities $3B $2.6B $2.5B $2.4B $2.4B
Total Equity $3.6B $3.9B $4B $4.3B $3.1B
Total Debt $1.8B $1.3B $1.4B $1.5B $1.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $208.4M $284M $306.1M $95.5M $70.7M
Cash From Investing -$367.6M -$50.9M -$59.8M -$25M -$30.6M
Cash From Financing $82.6M $47.3M -$99.5M $114.5M -$100.5M
Free Cash Flow $140.9M $217.1M $272.7M $77.1M $63.3M
NVST
Sector
Market Cap
$3.2B
$45.6M
Price % of 52-Week High
73.32%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-22.28%
-31.35%
Beta (5-Year)
1.315
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $19.04
200-day SMA
Sell
Level $18.89
Bollinger Bands (100)
Sell
Level 17.49 - 20.61
Chaikin Money Flow
Sell
Level -61.7M
20-day SMA
Sell
Level $20.32
Relative Strength Index (RSI14)
Sell
Level 39.38
ADX Line
Sell
Level 16.2
Williams %R
Neutral
Level -74.7126
50-day SMA
Sell
Level $20.06
MACD (12, 26)
Sell
Level -0.53
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Sell
Level -137.5M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7199)
Buy
CA Score (Annual)
Level (0.3142)
Buy
Beneish M-Score (Annual)
Level (-2.738)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.8954)
Buy
Piotroski F Score (Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company’s Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company’s Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Stock Forecast FAQ

In the current month, NVST has received 3 Buy ratings 10 Hold ratings, and 1 Sell ratings. The NVST average analyst price target in the past 3 months is $21.33.

  • Where Will Envista Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Envista Holdings share price will rise to $21.33 per share over the next 12 months.

  • What Do Analysts Say About Envista Holdings?

    Analysts are divided on their view about Envista Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Envista Holdings is a Sell and believe this share price will drop from its current level to $17.00.

  • What Is Envista Holdings's Price Target?

    The price target for Envista Holdings over the next 1-year time period is forecast to be $21.33 according to 14 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.

  • Is NVST A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Envista Holdings is a Hold. 10 of 14 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of NVST?

    You can purchase shares of Envista Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Envista Holdings shares.

  • What Is The Envista Holdings Share Price Today?

    Envista Holdings was last trading at $18.97 per share. This represents the most recent stock quote for Envista Holdings. Yesterday, Envista Holdings closed at $18.80 per share.

  • How To Buy Envista Holdings Stock Online?

    In order to purchase Envista Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
73
PSIX alert for Dec 24

Power Solutions International [PSIX] is up 27.42% over the past day.

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 8.07% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is down 1.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock